Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

15

Revenue 2017

Neulasta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Neulasta was produced by Amgen.

Amgen cuts workforce and facilities despite profit leap

Amgen cuts workforce and facilities despite profit leap Ageing white blood cell stimulators Neupogen (filgrastim) and Neulasta (pegfilgrastim) also shrugged off emerging competition in the US and Europe, with sales down just 1 per cent to $1.4bn.  .

Back to the future

Back to the future Increased sales from its two biggest franchises, Enrel and Neulasta, as well as the late 2013 acquisition of Onyx, contributed to its growth.

Pharma's winners and losers in 2013

Pharma's winners and losers in 2013 The US biotech saw increased sales from its two biggest selling franchises, Enbrel (etanercept) and Neulasta (pegfilgrastim), while also building on the early success of osteoporosis therapy Prolia (denosumab) , sold as

Teva withdraws US filing for cancer biologic

Teva withdraws US filing for cancer biologic Neulasta (pegfilgrastim). ... Together, Amgen's two products achieved worldwide sales of $4.83bn in the first nine months of 2013, with Neulasta accounting for $3.29bn of that total.

Amgen buys total filgrastim rights from Roche

Amgen buys total filgrastim rights from Roche Teva is building up for launch of a filgrastim product in the US after November 10 - when Neupogen's patents expire - while Neulasta is facing generic competition from 2015. ... while Neulasta gained 9 per cent to $1.14bn thanks to price increases and a

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....